• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Serine incorporator 5 (SERINC5), Truncated

ACP06270

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP06270 Target NameSERINC5
Target SynonymsC5orf12; SERC5_HUMAN; SERINC5; Serine incorporator 5; TPO1FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ86VE9
Background Information
  • Uniprot Id

    Q86VE9

  • Target Species

    Human

  • Target Name

    SERINC5

  • Target Full Name

    Serine incorporator 5

  • Target Function

    Restriction factor required to restrict infectivity of lentiviruses, such as HIV-1: acts by inhibiting an early step of viral infection. Impairs the penetration of the viral particle into the cytoplasm. Enhances the incorporation of serine into phosphatidylserine and sphingolipids. May play a role in providing serine molecules for the formation of myelin glycosphingolipids in oligodendrocytes.

  • Target Subcellular Location

    Cell membrane; Multi-pass membrane protein.; Cytoplasm, perinuclear region.

  • Target Protein Families

    TDE1 family

  • Target Tissue Specificity

    Highly expressed in placenta, skeletal muscle, spleen, thymus, testis and peripheral leukocyte and is expressed weakly in the heart, liver and fetal brain.

  • Target Synonyms

    C5orf12; SERC5_HUMAN; SERINC5; Serine incorporator 5; TPO1

Inquire Recombinant Human Serine incorporator 5 (SERINC5), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification